PI3K/AKT signal pathway: a target of natural products in the prevention and treatment of Alzheimer's disease and Parkinson's disease

HZ Long, Y Cheng, ZW Zhou, HY Luo… - Frontiers in …, 2021 - frontiersin.org
Alzheimer's disease (AD) and Parkinson's disease (PD) are two typical neurodegenerative
diseases that increased with aging. With the emergence of aging population, the health …

Distinct functions of AKT isoforms in breast cancer: a comprehensive review

N Hinz, M Jücker - Cell Communication and Signaling, 2019 - Springer
Background AKT, also known as protein kinase B, is a key element of the PI3K/AKT
signaling pathway. Moreover, AKT regulates the hallmarks of cancer, eg tumor growth …

PI3K-AKT-mTOR and NFκB pathways in ovarian cancer: implications for targeted therapeutics

A Ghoneum, N Said - Cancers, 2019 - mdpi.com
Ovarian cancer is the most lethal gynecologic malignancy in the United States, with an
estimated 22,530 new cases and 13,980 deaths in 2019. Recent studies have indicated that …

[HTML][HTML] The PI3K-AKT pathway: A plausible therapeutic target in Parkinson's disease

A Goyal, A Agrawal, A Verma, N Dubey - Experimental and Molecular …, 2023 - Elsevier
Parkinson's disease is a common progressive and multifactorial neurodegenerative disease,
characterized by the loss of midbrain dopaminergic neurons. Numerous pathological …

AKT1 and AKT2 isoforms play distinct roles during breast cancer progression through the regulation of specific downstream proteins

M Riggio, MC Perrone, ML Polo, MJ Rodriguez… - Scientific reports, 2017 - nature.com
The purpose of this study was to elucidate the mechanisms associated with the specific
effects of AKT1 and AKT2 isoforms in breast cancer progression. We modulated the …

Molecular interactions of miR-338 during tumor progression and metastasis

M Moghbeli - Cellular & molecular biology letters, 2021 - Springer
Background Cancer, as one of the main causes of human deaths, is currently a significant
global health challenge. Since the majority of cancer-related deaths are associated with late …

Targeting the PI3K pathway and DNA damage response as a therapeutic strategy in ovarian cancer

TT Huang, EJ Lampert, C Coots, JM Lee - Cancer treatment reviews, 2020 - Elsevier
Ovarian cancer is the most lethal gynecological malignancy worldwide although exponential
progress has been made in its treatment over the last decade. New agents and novel …

miRNA-dependent regulation of AKT1 phosphorylation

MI Frederick, T Siddika, P Zhang, N Balasuriya… - Cells, 2022 - mdpi.com
The phosphoinositide-3-kinase (PI3K)/AKT pathway regulates cell survival and is over-
activated in most human cancers, including ovarian cancer. Following growth factor …

Melatonin and cisplatin co-treatment against cancer: a mechanistic review of their synergistic effects and melatonin's protective actions

M Rafiyan, A Davoodvandi, RJ Reiter… - … -Research and Practice, 2024 - Elsevier
Combination chemotherapy appears to be a preferable option for some cancer patients,
especially when the medications target multiple pathways of oncogenesis; individuals …

Revisiting ovarian cancer microenvironment: a friend or a foe?

B Zhang, F Chen, Q Xu, L Han, J Xu, L Gao… - Protein & …, 2018 - academic.oup.com
Abstract Development of ovarian cancer involves the co-evolution of neoplastic cells
together with the adjacent microenvironment. Steps of malignant progression including …